Concentration and diversification

Exchange funds: are they actually worth it?

Contribute appreciated stock to a pooled fund, receive a diversified basket, pay no tax on the swap: that is the exchange fund pitch. The structure works, but you pay with a seven-year hold, fee drag on the whole position, and a tax bill that is deferred, not erased. It earns its keep for a narrow profile: very low basis, very large position, no cash need for seven-plus years. For most equity holders, a scheduled sell-down wins. Here is the comparison the pitch leaves out.

Published June 11, 2026 · Concentration mistakes, Hedging mistakes, and others →

If you hold a large, low-basis stock position, sooner or later someone pitches you an exchange fund. The pitch is clean: contribute your concentrated shares to a pooled fund, receive a slice of a diversified portfolio, and trigger no capital gains tax on the swap. Diversification without the tax bill. The pitch is real as far as it goes. What it usually leaves out is a seven-year lockup, a cost basis that follows you out the door, fees charged on the whole position rather than the tax you deferred, and the comparison against simply selling on a schedule. This article runs that comparison.

One naming collision to clear first: an exchange fund (sometimes called a swap fund) has nothing to do with an exchange-traded fund (ETF). The “exchange” is you swapping your shares for fund units, not a stock exchange.

An exchange fund defers your tax bill. It does not erase it. You pay for the deferral with seven years of lockup and fee drag, and the gain is still attached to the basket when you leave.

What an exchange fund actually is

An exchange fund is a limited partnership. Each investor contributes an appreciated concentrated stock position and receives partnership units representing a pro-rata interest in the whole pool. After enough contributors, the pool itself is diversified, so your units are too. Sponsors are large brokerages and a handful of specialist firms; most sponsors gate access to qualified purchasers ($5 million or more in investments, the Investment Company Act threshold), with some newer entrants open to accredited investors at lower minimums.

The tax engine is Internal Revenue Code (IRC) §721: contributing property to a partnership in exchange for a partnership interest is not a recognition event. No sale, no capital gain, no tax due at contribution.

There is a catch inside the statute itself. §721(b) denies that treatment when the partnership would be an investment company, which a pool of marketable stocks normally would be. Funds manage around the exception by holding at least 20 percent of the portfolio in qualifying illiquid assets, usually direct real estate interests. So a typical exchange fund is roughly 80 percent contributed stocks and 20 percent real estate, a mix chosen to stay clear of that exception rather than for anyone's investment view. You are underwriting that real estate sleeve whether or not you wanted real estate.

The mechanics, and the catches

  • The seven-year hold. Partnership rules (IRC §704(c)(1)(B) and §737) claw the deferral back if contributed property is distributed within seven years of contribution. The lockup itself lives in the fund documents; those rules are why it is there. So the fund holds you for seven years, after which it can redeem your units in kind with a diversified basket of securities, still with no tax due. The diversification you came for arrives, fully and cleanly, only at the end.
  • Carryover basis: deferral, not elimination. Your basis in the units equals your basis in the contributed shares, and the basket you eventually receive inherits it. Sell the basket and the old gain comes due at whatever long-term capital gains (LTCG) rates then apply. What you bought is time, plus the ability to spread the eventual gain across many names and many sale years instead of one.
  • Early exit hands your own shares back. What an early redemption returns is set by each fund's documents; the common structure hands back your original contributed shares, not the basket, often net of fees and sometimes net of any basket appreciation. You leave with the concentration problem you arrived with, minus the fees you paid along the way.
  • Fee drag on the full position. Management fees vary by sponsor, and they sit well above what you would pay an index fund for the diversified exposure you end up with. The number that matters is not the headline percentage but the multiplication: annual fee, times your full position value, times seven years. Run it against the value of the deferral (next section) before signing anything.
  • You do not control the basket. The pool is whatever the other contributors brought, plus the mandatory illiquid sleeve. Since concentrated positions cluster in large-cap tech, the basket often tilts toward exactly the exposure you were trying to dilute. Ask for the current holdings before assuming the diversification is the kind you want.

What the deferral is actually worth

“No tax today” sounds like the whole gain is saved. It is not. The value of deferral is narrower: it is the return you earn on the not-yet-paid tax during the deferral window. That number is computable, and it is the number the fees have to beat.

The alternatives it competes with

Staged selling

The default move: sell on a multi-year schedule, pay LTCG as you go, reinvest the proceeds in a diversified portfolio you control. The cost is known and paid up front; what you get is full diversification on your timeline, no lockup, no ongoing fees beyond the index fund's, and a clean exit that completes instead of deferring. Spreading sales across years can also keep each year's gain in lower brackets. The concentration risk article covers schedule design in depth.

Zero-cost collars

If the goal is downside protection rather than diversification, a collar bounds the position (long put below, short call above) with no tax event and no lockup, at the cost of capped upside. It is the deferral structure you can unwind next month if you change your mind. The zero-cost collars article runs that math.

The one-sentence alternatives

Two more belong on the list, each in one sentence. If you have real philanthropic intent, donating appreciated shares or funding a charitable remainder trust removes the gain entirely for the donated portion, which deferral never does. And if the honest plan is to never sell, holding until death and passing the position with a stepped-up basis under IRC §1014 is the deferral endgame the exchange fund is approximating, without the fees.

Price the baseline before you sign

Every version of this decision reduces to one quantity: after-tax wealth at your horizon, under your return assumptions, for each path. The exchange fund pitch quotes the tax you avoid today; the right comparison is what you end up with later. That starts with pricing the sell-now baseline, because the deferral is only worth what selling would have cost.

The Stock Concentration Calculator computes that baseline for your actual numbers: the full tax bill of de-concentrating (federal LTCG, NIIT, and state, sliced across brackets), one-, two-, and three-year sell schedules, and the after-tax wealth each path leaves at the end of its three-year horizon, with a custom planner where holding and hedging are also on the menu. If the tax bill it shows is small relative to your position, stop reading about exchange funds; the simple path is cheap enough.

When an exchange fund makes sense, and when it does not

It earns its keep when most of these are true:

  • Very low basis. The deferred tax, and therefore the prize, is large relative to the position.
  • Very large position. You clear the qualified-purchaser gate, and the fixed costs of the structure are small against the deferral value.
  • No liquidity need for seven-plus years. The lockup costs you nothing because you were not going to touch the money anyway.
  • Estate planning is part of the picture. Deferral that chains into a basis step-up stops being deferral and becomes elimination.

It does not make sense when:

  • You may need the cash within seven years. The early-exit terms return your own shares; the structure fails exactly when you need it to work.
  • The position is small enough that staged selling is cheap. If spreading sales across two or three tax years keeps the LTCG bill tolerable, the simple path wins on cost, control, and finality.
  • You think the stock will underperform. Then sell it. Your shares stay in the pool you now own a slice of, an early exit hands them back to you, and the deferral math assumes the value you are deferring tax on survives the seven years.

So, are they worth it?

For a narrow profile, yes: an equity holder with a very large, very low-basis position, no use for the money for seven-plus years, and ideally an estate plan that turns the deferral into a step-up. For that profile, the deferral value is large, the lockup is costless, and the fees are a fair toll.

For most equity holders, no. The fee drag runs against the whole position while the benefit runs only on the deferred tax, the basket may not be the diversification you wanted, the gain is still waiting at the end, and a scheduled sell-down delivers controlled, completed diversification for a known one-time cost. Price that cost first. If it is bearable, the seven-year structure is solving a problem you can solve by Tuesday.

Where to go from here

Start with the Stock Concentration Calculator to size your drawdown exposure and the true cost of selling on a schedule. The concentration risk article covers the full menu of de-concentration tools, and the funding a goal article covers the case where the sale has a deadline attached.

The calculators here handle one decision in isolation. OptionsAhoy plans the full picture jointly: every ISO, NSO, RSU vest, concentrated position, and hedge, across bullish, neutral, and bearish scenarios. The output is a year-by-year Plan optimized for total after-tax wealth. Free during beta.

Educational content for general information, not personalized tax, legal, or financial advice. Consult a qualified professional for your specific situation. See Terms.

Run the numbers

Quantify your concentration with your own grant

The article lays out the framework. The stock concentration calculator runs it for your specific numbers in seconds. Free, no signup.

Open the Stock Concentration Calculator

You read the framework. Beta runs it on every grant you own.

OptionsAhoy plans every ISO, NSO exercise, RSU vest, hedge, and sale jointly across years and across bullish, neutral, and bearish scenarios. Free during beta.

Request beta access